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Nonfetal Imaging During
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KEY POINTS
 Placenta is a vital organ connecting the maternal and fetal circulations.
 Placenta accreta spectrum disorders and placental masses are the most common indications for
dedicated placental imaging with ultrasound or MR imaging.
 Placental accreta spectrum disorders present with characteristic imaging findings of irregular lakes,
myometrial thinning, abnormal intraplacental vascularity, and placental bulge on ultrasound and
MR imaging. Imaging is helpful in assessing the extent of involvement and presurgical planning.
 Antepartum hemorrhage is an important cause of maternal and fetal morbidity and mortality, and
most of the cases are due to placenta abnormalities including placenta previa and placental abrup-
tion. MR imaging can help distinguish hematomas from other causes of antepartum bleeding, such
as vasa previa, degenerated uterine fibroid, cervical pathology, and placental tumors.
 Placental masses are most commonly identified during the routine fetal ultrasound examinations.
Imaging evaluation should focus on the effect of the mass on fetal well-being in this scenario.INTRODUCTION
Placenta is a vital organ that allows exchange of
nutrients and gases between the mother and the
developing fetus.1 The placenta develops by 10
to 14 weeks of pregnancy and is fully functional
by the end of the first trimester to support the hor-
monal needs of continuing the pregnancy and the
metabolic needs of the developing fetus. As such,
disease states that affect the placenta can have
important consequences for both the mother and
the fetus.1,2
Ultrasound (US) is the first line of imaging for
most placental diseases. Per guidelines, all preg-
nancies should have an “anatomy scan,” also
called as a level one scan, at 18 to 20 weeks of
gestation.3 Although most of this scan focuses
on assessing the anatomic development of thea Department of Radiology and Biomedical Imaging, U
Avenue, Box 0628, San Francisco, CA, USA; b Departmen
sity, Via Silvestro Gherardi 38, 00146 Rome, Italy
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0033-8389/20/ 2019 Elsevier Inc. All rights reserved.fetus, evaluating the placenta is a crucial compo-
nent of this examination.3 MR imaging has an
increasingly important role as an adjunct modality
for imaging for placental disease processes as
well and can be particularly helpful for trouble-
shooting and advanced evaluation.4,5
The most common placental pathologies for
which imaging is necessary include placenta
accreta spectrum disorders (PASD) and placental
masses. Both processes are relatively uncommon;
however, the adverse consequences to both the
fetus and the mother are substantial and hence
should be specifically sought after and never over-
looked. This review addresses the normal anat-
omy of the placenta, imaging technique and
protocols, imaging findings and summarizes the
key information that needs to be conveyed to the
clinical providers.niversity of California San Francisco, 505 Parnassus
t of Radiology, Umberto I Hospital, Sapienza Univer-
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Fig. 1. Different types of cord insertion. (A) Grayscale and (B) color Doppler images demonstrate central cord
insertion (arrow) to posterior placenta (asterisk). (C) Transabdominal grayscale and (D) color Doppler images
demonstrate cord insertion into the chorioamniotic membranes and uterus away from the placenta (arrow).
The cord travels within the membranes toward the placenta diagnostic of a velamentous cord insertion. (E, F)
When fetal MR imaging is performed for other reasons, cord insertion may be easily detectable as on these cor-
onal T2-weighted images demonstrating velamentous cord insertion (arrow) into the uterus and the cord trav-
eling in the fetal membranes (short arrows) toward the placenta. (G, H) Transabdominal grayscale and color
Doppler images demonstrate marginal cord insertion at the edge (arrow) of the posterior placenta (asterisk).
Jha et al382NORMAL ANATOMY AND IMAGING
TECHNIQUE
The normal placenta is a discoid structure with
tapering edges, which attaches to the myome-
trium in a uniformly layering fashion. It measures
up to 4 cm in maximum thickness. The umbilical
cord mostly inserts centrally into the placenta
but can be marginal or velamentous as well
(Fig. 1). Normally, the lower placental edge
should be at least 2 cm from the margin of the in-
ternal cervical os.6 If less than 2 cm from the in-
ternal os, this counts as placenta previa. When
the placenta covers the internal os, this consti-
tutes complete previa (Fig. 2). Sometimes,
variant anatomy such as succenturiate lobe
(portion of the placenta separate from the mainplacental mass) and vasa previa (Fig. 3) are pre-
sent, which are extremely important to detect
and relay to the clinicians because of the risk
of retention of this lobe during delivery and
both conditions being at high risk for significant
hemorrhage.7
The normal placenta is homogeneous, slightly
hyperechoic relative to the myometrium on gray-
scale US (Fig. 4).1 On high-frequency and high-
resolution images, the placenta may seem
slightly less hyperechoic and overall the myome-
trium seems more closer in echogenicity to the
placenta. Hence, this relative difference in echo-
genicity is based on sonographic technical pa-
rameters (see Fig. 4). Very few lakes may be
present, especially adjacent to the placental
cord insertion.8 On color Doppler imaging, few
Fig. 1. (continued)
Nonfetal Imaging During Pregnancy 383small caliber intraplacental vessels and subpla-
cental vascularity can be seen.8 On MR imaging,
placenta is mostly isointense to the myometrium
on T1-weighted images and hyperintense to the
myometrium on T2-weighted (T2W) images
(Fig. 5). Sometimes, the pregnant uterus can
develop vascular congestion, in which case the
myometrium demonstrates T2-hyperintense
appearance. In such cases, the placenta rela-
tively seems iso- to hypointense to the myome-
trium (see Fig. 5). With increasing gestational
age, structure of the cotyledons becomes more
apparent and results in decreased signal inten-
sity to intermediate signal intensity compared
with the surrounding myometrium (Fig. 6).9,10
First and second trimester placentas are very ho-
mogeneous in their appearance but with devel-
opment of this lobular pattern, the placenta
becomes less homogeneous in appearance, asthin hypointense septa become apparent be-
tween the lobules on T2W images (see Fig. 6).
Placental septa and cotyledons are more often
visible when MR imaging is performed with a
3 T system.7
The placental-myometrial interface is demon-
strated as a retroplacental clear space on US
and as T2-hypointense interface on MR imaging.
Given the isointensity of the placenta to the myo-
metrium on T1-weighted images, the interface
is not well seen and is best evaluated on T2W
sequences. The normal subplacental vascularity
can be seen as multiple flow voids in this subpla-
cental space. A few flow voids can be
present within the placenta adjacent to the
umbilical cord insertion. The myometrium has
a variable thickness and thins as the
pregnancy progresses. The underlying myome-
trial wall thins as the pregnancy advances, and
Fig. 2. Complete placenta previa. (A)
Endovaginal image of placenta
(asterisk) completely covering internal
os (arrow). (B) Sagittal T2-weighted
MR image demonstrates placenta
(asterisk) completely covering the in-
ternal os (arrow).
Jha et al384this finding alone does not imply PASD.11 The
myometrium naturally thins at sites of compres-
sion, such as adjacent to the maternal spine
and aorta, appearing as a single thin layer of uni-
form signal on T2W images. In addition, the myo-
metrium is expected to thin as the gestation
progresses, especially at the site of previous
scars.12IMAGING PROTOCOLS
Ultrasound
US images should evaluate the entire placenta,
and images should be acquired documenting
that the entire placenta has been evaluated.
Grayscale as well as Doppler imaging should
be used. Based on body habitus and depth of
the placenta, evaluation with a curvilinear 2 to
6 Megahertz (mHz) and 9 mHz linear transducers
can be performed.13,14 In all pregnancies,
placenta should be evaluated for the location
of implantation, proximity to the cesarean sec-
tion scar (if applicable), placenta previa or vasa
previa, succenturiate lobe, and shape and thick-
ness of the placenta. After this generalevaluation, particularly in patients with history
of uterine intervention such as cesarean section,
myomectomy, embolization, or Asherman syn-
drome, attention should be drawn to specific
findings of PASD such as placental heterogene-
ity, irregular lacunes or placental lakes, loss of
retroplacental clear space/subplacental lucency,
myometrial thinning, abnormal subplacental and
intraplacental vascularity, placental bulge, and
extrauterine invasion (such as that into the
bladder or the parametrium). Studies have
shown improved patient outcomes when tar-
geted evaluation of the placenta is performed
in patients with suspected PASD.15 Details of
these findings are discussed later in this article.
In addition, with placental evaluation, it is imper-
ative to evaluate the area of the internal os with
color Doppler imaging to evaluate for any aber-
rant vessels at this location. If any vessels are
present, they can be further evaluated with
spectral Doppler to look for their maternal versus
fetal origin, based on heart rate observations.
Vessels demonstrating arterial waveforms at
fetal heart rate are highly suspicious for vasa
previa.Fig. 3. Vasa previa. (A) Endovaginal im-
age demonstrates a crossing vessel
over internal os (arrow) with fetal
heart rate diagnostic of vasa previa.
(B) MR imaging sagittal ssFSE per-
formed on the same day correlated
with this finding (arrow). Patient had
ruptured membranes, and fluid
around the vessels outlined the
finding. Fluid is seen in the upper va-
gina from ruptured membranes (short
arrow). ssFSE, single-shot fast spin
echo.
Fig. 4. Normal sonographic appear-
ance of the placenta. (A) Transabdomi-
nal US demonstrated homogeneously
hyperechoic second trimester placenta
(asterisk) in relationship to hypoechoic
myometrium (arrows). (B) High-
resolution image performed with a
linear transducer shows the normal
placenta (asterisk) to be slightly less hy-
perechoic, and the myometrium (ar-
rows) does not seem as hypoechoic in
comparison to the placenta. The over-
all relative signal of these structures
depends on imaging parameters.
Nonfetal Imaging During Pregnancy 385MR Imaging
The authors’ institutional MR imaging protocol for
placental imaging is summarized in Table 1. In
brief, a combination of T2 (not fat suppressed)
and T1 images are necessary. Most of the findings
for PASD and placental masses are evident on
nonfat-suppressed T2W images. T1 images are
essential to evaluate for intrinsic hyperintensity
secondary to hemorrhage in PASD and to detect
the presence of fat in placental masses. Occasion-
ally, fat-suppressed T1 images may be needed,
when evaluating for the presence of fat in placental
masses. The role of diffusion-weighted imaging in
placental imaging is still evolving. In the author’s
experience, DWI is particularly helpful in cases
with severe myometrial vascular congestion, to
help delineate the placental-myometrial interface.
In this scenario, the placenta demonstrates hyper-
intensity, whereas the myometrium does not and
hence making their interface better visualized.Technical details of MR imaging for the placenta
are summarized in Michael A. Ohliger and Hailey
H. Choi’s article, “Imaging Safety and Technical
Considerations in the Reproductive Age Female,”
in this issue.
IMAGING FINDINGS/PATHOLOGY
Placenta Accreta Spectrum
PASD is a spectrum of disorders where the
placenta adheres to the underlying myometrium
and hence does not separate at the time of deliv-
ery, leading to massive hemorrhage, which can
be life threatening to the mother. The spectrum
includes accreta (where the placenta is attached
directly to the myometrium, without intervening
decidua), increta (with myometrial invasion),
and percreta, where the placenta extends
outside the uterine serosa and possibly into
adjacent organs such as the bladder and the
parametrium. International Federation ofFig. 5. Normal MR imaging appear-
ance of the placenta. (A) Sagittal and
(B) axial T2W MR images in second
trimester demonstrate a homogeneous
placenta (asterisk), slightly hyper to
isointense to myometrium (arrows).
The signal of myometrium varies on
T2W images that depend on the de-
gree of physiologic vascular engorge-
ment. As seen in (B), numerous flow
voids may be present in the physiolog-
ically engorged myometrium (arrows).
Fig. 6. Normal appearance of a
“mature” placenta in late gestation.
(A) Transabdominal image performed
with high-resolution linear transducer
of a patient in the third trimester dem-
onstrates the placenta (asterisk) to be
hyperechoic relative to the myome-
trium (arrows) and overall more het-
erogeneous in appearance. (B)
Sagittal T2W MR image in a patient
in her third trimester demonstrates
the placenta (asterisk) to be more het-
erogeneous in signal as well.
Jha et al386Gynecology and Obstetrics has proposed a
combined clinical-pathologic classification,
which includes both intraoperative observations
as well as findings on gross pathology.16 Often
relying on pathology alone can lead to erroneous
estimation of the severity of the findings, leading
to this combined system.16 No single imaging
feature has been shown to be diagnostic for
PASD, and usually a combination of multiple
findings exists, alerting the reviewers to the cor-
rect diagnosis.
Ultrasound
On US some of the commonly reported signs are
the presence of multiple placental lakes with irreg-
ular margins (Fig. 7), the loss of retroplacental
clear space, between the placenta and the myo-
metrium (see Fig. 7), and presence of placenta
previa (see Fig. 7). Other features include hetero-
geneous placenta, asymmetry of placental thick-
ness, myometrial thinning, bladder wall
interruption, myometrial, and bladder wall hyper-
vascularity (see Fig. 7).
Prominent placental lacunes This is the most
commonly reported US finding of abnormal
placentation, which is present irrespective of the
depth of invasion (see Fig. 7).14,17 Placental
lacunes are vascular anechoic or hypoechoic
structures located within the center of the cotyle-
dons. Although a few of these are often present
in normal placentae, imaging findings of PASD
represent a spectrum of worsening appearance,
as they become larger, irregular, and concentrated
in the area of invasion and can demonstrate slow
internal flow on real-time imaging.14,17 These arealso often referred as “placental lakes” and give
the placenta the classic “moth-eaten”
appearance.14,17
Loss of retroplacental clear space The normal
placental-myometrial interface seems hypoechoic
on gray-scale US, which represents the normal
decidua basalis. With PASD, this clear space is
obliterated (see Fig. 7),13,17–19 and approximately
70% of cases will show this finding.17 In some
cases, this area can have prominent subplacental
vascularity.
Myometrial thinning In cases of PAS, myome-
trium may be thinned to submillimeter levels and
actually becomes undetectable in more severe
cases (see Fig. 7).14,17 It is reported to occur in
about 50% of cases, which may be reflective of
US changes that happen at the more invasive
end of the spectrum.14,17
Placental bulge sign With deeper depths of inva-
sion, the placenta may bulge outward, creating
an hourglass or snowman configuration of the
uterine contour. Along with myometrial thinning,
this finding highly suggests myometrial invasion
(Figs. 8 and 9).
Bladder wall interruption Bladder wall interrup-
tion is defined as the interruption of the hypere-
choic fat plane between the uterus and the
bladder, which can involve the bladder wall and
extend into the bladder lumen in the most severe
cases.14,20,21 Prominent vessels may be identified
at the bladder wall, but these are not specific for
invasion (see Fig. 7).14 Spectral interrogation of
these vessels can be performed, and if fetal heart
Table 1
MR imaging protocol for placental imaging at 3 T
Coverage TR TE Flip NEX Slice Matrix FOV Phase Oversample
Patient should drink water before commencing study
Coronal, axial, and sagittal
single-shot fast spin echo (ssFSE)
Uterus to below cervix 2000 100 X X 4/0 384x256 36 R > L PE FOV 1.0
Axial LAVA FLEX or mDIXON
DUAL ECHO
Center over the placenta 4.2 1.2 15 1 3/0 260x256 34 A > P PE FOV 1.1
Coronal ssFSE (nonpropeller) High-resolution imaging
(reduced field of view),
center over the placenta
2000 100 X X 4/0 384x256 26–28 R > L PE FOV 1.0
Axial T2 FSE (nonpropeller) No fat saturation, high-resolution
imaging (reduced field of view),
center over the placenta
4000 120 120 2 4/0 320x256 24 R > L NPW
Sagittal T2 FSE propeller No fat saturation, high-resolution
imaging (reduced field of view),
center over the placenta
11,000 74 2 4/0 256x256 24
Axial and sagittal diffusion-weighted
imaging (DWI)
Multiple b-values of 0, 50, 500,
1000: ADC maps
Routine field of view
5000 30.5 2 6/0 80x80 34 PE FOV 1
Abbreviations: ADC, apparent diffusion coefficient; FOV, field of view; NEX, number of excitations; TE, the echo time; TR, the repetition time.
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Fig. 7. US features of placenta accreta spectrum (PAS). (A) Endovaginal grayscale image demonstrates complete
placenta previa with multiple placental lakes with irregular margins (arrows) and loss of retroplacental clear
space (short arrows). (B) Endovaginal image with color Doppler demonstrates loss of retroplacental clear space
and increased retroplacental vascularity (arrow). (C) Endovaginal image demonstrates extensive bladder wall hy-
pervascularity (arrows). (D) Intraoperative cystoscopy image obtained during delivery demonstrates prominent
submucosal vascularity (arrowhead).
Jha et al388rate can be demonstrated, it highly suggests
bladder invasive PASD.
Asymmetric thickness Invasive placentas often
appear thickened in the portion implanted
on the cervix, and overall the placental thick-
ness is increased in the areas involved by
PASD.22MR imaging
MR imaging is now recognized for its strengths in
assessment of invasive placentation.4 MR imag-
ing provides supplemental knowledge in addition
to US, particularly in cases of posterior and lateral
invasion, areas that may be technically chal-
lenging for US imaging23,24 (see Fig. 8). At the au-
thors’ institution, any patient with suspicion forFig. 8. MR imaging appearance of
placenta accreta spectrum. (A) Sagittal
T2W image demonstrates posterior
placenta with bulge (dotted line) into
the myometrium. (B) During the sur-
gery a subtle blue bulge was noted
on the posterior uterus (arrows). Cesar-
ean hysterectomy specimen confirmed
placenta increta on pathology.
Fig. 9. MR imaging appearance of placenta accreta spectrum with intraoperative correlation. (A) Sagittal T2W
MR image demonstrates complete placenta previa (black arrow) with bulging of lower uterine segment and
barely visible retroplacental myometrium (arrowheads). T2-dark bands are present in the placenta (white arrow).
(B) Intraoperative US confirms the bulge and retroplacental thinning of myometrium (arrowheads). (C) Intraoper-
ative picture demonstrates a uterine bulge with blue tinge (arrow) corresponding to imaging findings. Gross pa-
thology confirmed placenta increta.
Nonfetal Imaging During Pregnancy 389invasive placenta based on US findings un-
dergoes MR imaging of the placenta and
uterus.23,24 If normal placentation is confidently
diagnosed with US, patients may not be referred
for additional imaging. Although MR imaging has
similar overall sensitivity and specificity to US, it
has been shown to have a high predictive accu-
racy in assessing both the depth and topography
of placental invasion.4 It has also been beneficial
in cases with clinical suspicion for accreta and
discordant US findings and in cases in which per-
creta is suspected.23 MR imging is also helpful for
surgical planning. Knowing the location of the
placenta and its relationship to cervix, bladder,
and pelvic sidewall allows for preoperative plan-
ning for stents, embolization, and extent of
dissection anticipated. Recent work by Bourgioti
and colleagues25,26 has demonstrated MR imag-
ing to be capable of assessing extrauterine
spread as well as predict adverse maternal and
neonatal outcomes. Similar to US, myometrialthinning, asymmetric placental thickening, and
bladder wall interruption are also present on MR
imaging. Most commonly reported MR imaging
findings for PASD, in addition to findings recog-
nized on US, are described below.
T2-dark bands Dark intraplacental bands are
linear or polygonal areas of very low signal inten-
sity on T2W images (see Fig. 9).12,27 They can be
of variable thickness with a maximum diameter
ranging from 6 mm to 20 mm or more and are
thought to represent areas of fibrin deposition
due to repetitive intraplacental hemorrhage or in-
farcts.4,12,27–29 Small intraplacental dark bands
may occasionally be noted in mature noninvasive
placentas (>30 weeks of gestation), typically on
the fetal surface of the placenta, whereas the
abnormal T2-dark bands usually contact the
maternal surface of the placenta.30 This feature is
considered one of the most consistent abnormal
MR imaging findings in patients with
PASD.6,25,28–31
Fig. 10. MR imaging appearance of placenta accreta
spectrum with placenta percreta. T2W sagittal image
demonstrates extremely heterogeneous placenta
(asterisk) invading (short arrows) into the lumen of
urinary bladder (UB).
Jha et al390Placental bulge sign One of the most commonly
reported MR imaging signs of PASD is abnormal
uterine bulging. When an abnormal placenta im-
plants in the lower uterine segment, the uterus
develops an hourglass or snowman configura-
tion, rather than the typical inverted pear shape
(see Figs. 8 and 9). This finding is best seen in
coronal and sagittal images but can be seen on
axial images too when the bulging is lateral in
location.11,30,32 The presence of uterine bulging
has been shown to be associated with deeper
depths of invasion.6,27,32–34 The investigators
have noted the presence of the bulge in patients
with increta5 as well as placenta percreta35 on
MR imaging.
Loss of retroplacental T2-hypointense line The
hypointense interface between placenta and myo-
metrium on T2W images corresponds to the retro-
placental hypoechoic zone described in obstetric
US and is best seen on T2W sequences.12 This
interface is lost in cases of PASD. This finding is
usually present along with focal myometrial de-
fects and thinning.31 In cases of placenta percreta,
placental tissue can be seen extending through
the myometrium with disruption of this T2-
hypointense line.36
Myometrial thinning Myometrium can be thinned
at the placental attachment to less than 1 mm in
thickness and even essentially becomes imper-
ceptible with PASD.37 This is also best assessed
on T2W sequences.11,38,39 However, because
there is some expected thinning of the myome-
trium as pregnancy progresses, myometrial visual-
ization becomes difficult as the pregnancy
progresses.11,12 When the myometrium is well
demonstrated, focal interruptions of the wall are
seen at sites of invasion with placental tissue
extending through the breach in case of percreta
(Fig. 10).4,33,40
Abnormal intraplacental vascularity and sub-
placental vascularity Abnormal vessels are
located in the placental parenchyma along with a
prominent network of vessels in the placental
bed with disruption of the uteroplacental interface
in cases of PASD. These vessels may extent to the
underlying myometrium, can reach up to the uter-
ine serosa, and may be accompanied by extensive
neovascularization around the bladder, uterus,
and vagina. A novel “stripped fetal vessel” sign
has been proposed, which refers to a large caliber
intraplacental vessel that travels between the fetal
and maternal placental surfaces without change in
caliber.41
The term “placental bed” refers to that part of
the decidua and adjacent myometrium thatunderlies the placenta and whose primary function
is the maintenance of an adequate blood supply to
the intervillous space of the placenta.42 Although it
is common to see flow voids here even in normal
pregnancies, in PASD these vessels are seen to
directly enter the placenta and can even course
up to the umbilical cord insertion.
PLACENTAL ABRUPTION
Placental abruption represents premature separa-
tion of the placenta from the uterine wall. Although
rare (affecting <1% of pregnancies), third-
trimester abruption is associated with an
increased risk of preterm delivery and fetal death.
Imaging appearance of placental abruption can be
classified based on the location of the hematoma
as retroplacental, marginal subchorionic, prepla-
cental, and intraplacental (Fig. 11).
US is frequently performed to confirm the
presence of abruption and assess the extent of
subchorionic or retroplacental hematoma.43
However, in up to 50% of cases of abruption
US is negative for different reasons: (1) acute
hemorrhage echo texture is very similar to that
of the adjacent placenta and is therefore very
Fig. 11. Coronal MR (A) T2-weighted, (B) T1-weighted, and (C) DWI demonstrate hyperacute placental abruption
(asterisk) with intermediate signal intensity on T2-weighted images, high signal intensity on T1-weighted images,
and reduced diffusion on high B-value images. (D) In a different patient, hemorrhage can be of very low signal
intensity on T2-weighted images as seen on this case of intraamniotic hemorrhage of subacute chronicity (arrow).
(E) Corresponding transabdominal US demonstrates diffuse echoes throughout the amniotic sac, correlating to
large amount of intraamniotic hemorrhage (asterisk).
Nonfetal Imaging During Pregnancy 391difficult to detect; (2) the imaging appearance of
an abnormally thick and heterogeneous placenta
is rare, being present only in large acute clots;
and (3) many subacute clots result in falsely
negative because blood dissects out from
beneath the placenta and drains through the cer-
vix.44,45 MR images have intrinsic high soft tissue
contrast and can accurately depict placental-
related hemorrhage with a reported high sensi-
tivity of 95% to 100% and high specificity of
100%.45 By considering the signal intensity
changes on T1-weighted, T2W, and diffusion-
weighted images, with special reference to the
paramagnetic effects of methemoglobin, it is
possible to estimate the age of the bleeding
(see Fig. 11).46 Hyperacute hemorrhage is usu-
ally hyperintense on T2W and diffusion-
weighted images, being iso- to hypointense on
T1-weighted images (see Fig. 11).46 Acute hem-
orrhage remains iso- to hypointense on T1-
weighted images but now becomes hypointense
on T2W and diffusion-weighed images.46 Sub-
acute hemorrhage is T1-hyperintense due to
presence of methemoglobin. Chronic hemor-
rhage is hypointense on all T1-weighted, T2W,
and diffusion-weighted images.46PLACENTAL MASSES
Uncommonly, the placenta can develop
masses, the most common of which is a cho-
rioangioma. Broadly, placental masses can be
classified as nontrophoblastic or trophoblastic
in origin.47 Trophoblastic masses include molar
pregnancy, intraplacental choriocarcinoma, and
complete hydatidiform mole with twin fetus.
Nontrophoblastic masses include chorioan-
gioma, placental teratoma, and placental
mesenchymal defect.47 Placenta can get metas-
tases from maternal primaries such as lung and
breast cancer but also fetal malignancy such as
neuroblastoma.47
Nontrophoblastic Placental Masses
Chorioangioma
The most common nontrophoblastic mass to
develop in the placenta is a chorioangioma.47 As
the name suggests, this is a benign proliferation
of the vascular channels supported by chorionic
stroma.48 Interestingly, these masses occur at an
unusual frequency in higher altitudes, and hypoxic
origin of these masses has been postulated.48
Most of these masses are small and
Jha et al392asymptomatic, being incidentally identified on US
performed for fetal well-being. The masses are
contiguous with fetal circulation, and resultant
arteriovenous shunting within the placenta can
be linked to several pregnancy complications,
including fetal anemia, thrombocytopenia, nonim-
mune fetal hydrops, polyhydramnios, antepartum
hemorrhage with premature placental detach-
ment, preterm labor, intrauterine fetal growth re-
striction (IUGR), and increased perinatal
mortality.48
On US, chorioangiomas appear as echogenic
masses, which are characteristically located adja-
cent to the placental cord insertion and protrude
into the amniotic cavity (Fig. 12). On Doppler inter-
rogation, internal vascularity pulsating at fetal
heart rate can be demonstrated, which is a hall-
mark for this diagnosis.48 Larger masses start
developing cystic areas and can even cause cho-
rioamniotic separation, secondary to profuse
mucin secretion (see Fig. 12).47 Once diagnosed,
careful assessment for polyhydramnios and fetal
anemia using middle cerebral arterial Doppler
assessment should be performed. On MR imag-
ing, these masses are isointense to the placenta
on T1-weighted images and are heterogeneous
being mostly hyperintense to the placenta on
T2W images (see Fig. 12).47 Intrinsic T1 hyperin-
tensity can develop at the periphery of the tumor
related to hemorrhage.
Placental teratoma
Teratomas are extremely rare benign tumors of the
placenta with a very favorable outcome. These
masses include components from all 3 germ cell
lines and always lie between the amnion and the
chorion, usually on the fetal surface of the
placenta.49 The sonographic andMR imaging find-
ings include demonstration of tissues of variable
echogenicities or signal intensities demonstrating
intratumoral fat, calcifications, and fluid.50 On
US, fat in a teratoma is hyperechoic to the normal
placenta, whereas intratumoral calcifications are
echogenic and demonstrate shadowing.50 Gesta-
tional trophoblastic disorders can too present as
hyperechoic masses but are unlikely to demon-
strate calcification.50 One of the major differentials
for a teratoma includes a fetus acardiac amor-
phous (fetus in fetu). This entity demonstrates
well-formed elements such as partial or complete
formation of a vertebral column, ribs, pelvis, and
skull base and sometimes a short umbilical cord
may be present connecting this to the placenta.50
Placental mesenchymal defect
Placental mesenchymal defect (PMD) is a rare
vascular anomaly of the placenta presenting asplacentomegaly, multicystic mass, and villous hy-
perplasia.51 Although this finding may be
completely incidental, preterm delivery, IUGR,
fetal anomalies (such as fetal liver cysts or vascular
malformations), fetal overgrowth with Beckwith-
Wiedemann syndrome, and even fetal demise
have been associated with this abnormality.51,52
Sonographic features include a multicystic mass,
which can closely mimic a partial mole appearing
given the presence of an enlarged placenta with
multiple cystic masses (Fig. 13).53 Differentiation
from a molar pregnancy is important for appro-
priate management so that the pregnancy is not
erroneously terminated. On color Doppler imag-
ing, some of these cystic spaces demonstrate
slow color flow, also called as a “stained-glass”
appearance to the placenta (see Fig. 13).54 In early
pregnancy, lack of flow or slow flow can help
differentiate PMD from chorioangioma and molar
pregnancies, but this distinction can be difficult
in later trimester due to overall increased flow to
the placenta. MR imaging also shows correspond-
ing findings of thickened placenta with multiple
cystic spaces (see Fig. 13). Ultimately, chromo-
somal abnormality helps differentiate these en-
tities, with PMD usually having a 46 XX
karyotype, where partial moles are triploid.47
Trophoblastic placental masses
Trophoblastic masses include hyaditiform mole
and intraplacental choriocarcinoma. Unusual
cases such as complete hyaditiform mole with
coexisting twin live fetus can also mimic a
placental mass. All the masses on the tropho-
blastic spectrum are associated with dispropor-
tionally elevated beta-human chorionic
gonadotropin (b-hCG) levels.
Intraplacental choriocarcinoma This is a rare
variant of the choriocarcinoma spectrum, which
is known to be associated with massive fetomater-
nal hemorrhage, likely due to villous erosion by the
growing tumor, leading to fetal anemia and even-
tual fetal demise.55 It should be considered in the
differential for massive fetomaternal hemorrhage
of unknown cause in the setting of an elevated b-
hCG. On US, small intraplacental choriocarci-
nomas can be occult and isoechoic to the
placenta.55 They can also present as hyperechoic
masses, whereas some may have cystic
changes.55 Retroplacental hemorrhage with
placental abruption can develop, which is respon-
sible for the associated fetomaternal hemor-
rhage.56 Metastases to both mother and fetus
can be present.56
Complete hydatidiform mole with twin live
fetus This is a rare entity in which a normal
Fig. 12. Chorioangioma. (A) Large mixed, solid, and cystic mass (arrows) is seen arising from the placenta and pro-
truding into the amniotic cavity. Echogenic foci throughout the mass represent scattered calcifications. (B) The
mass is characteristically located adjacent to the placental cord insertion. (C) On spectral Doppler interrogation,
the mass demonstrates internal vascularity pulsating at the fetal heart rate, also characteristic of a chorioan-
gioma. (D, E) Coronal T2W images demonstrate a heterogenous, exophytic mass (arrow) arising from the
placenta. (E) Separated amnion (black arrows) is seen consistent with chorioamniotic separation resulting from
excessive mucin secretion by chorioangiomas.
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Fig. 13. Placental mesenchymal
dysplasia. (A) On color Doppler US,
the placenta is noted to be thickened
with multiple tiny cystic spaces (ar-
row), which suggests PMD. (B) T2W
MR imaging redemonstrates the
thickened placenta with diffuse scat-
tered T2-hypointense cystic spaces
(arrow).
Jha et al394karyotype fetus develops along with an abnormal
molar pregnancy.57 This entity poses a significant
clinical challenge, leading to both maternal and
fetal morbidity. Maternal risks include preeclamp-
sia, hyperthyroidism, and possibly malignancy;
fetal complications include elevated risk of spon-
taneous abortion and neonatal thyrotoxicosis.47,57
Although the normal fetus can have a favorable
outcome, nearly 33% of the mothers develop
persistent gestational trophoblastic disease after
delivery.58
US findings include a multilocular cystic mass
on grayscale images. On Doppler US, overall
hypervascularity is seen without demonstrable
flow in the cystic components (Fig. 14), a finding
that helps differentiate from PMD.11,23 Identi-
fying this mass as separate from the placenta
of the normal twin is very important and helps
establish the diagnosis. This distinction is best
established in the early gestational period and
gets progressively more difficult with advancing
gestation. PMD on the other hand is integrally
intraplacental in location. MR imaging also dem-
onstrates the cystic nature of the mass and can
show the membrane separating the molar preg-
nancy from the normal pregnancy (see
Fig. 14).47 T1-weighted images best depict the
hyperintensity associated with hemorrhage,
which is common with molar pregnancies, andoften poorly identified on US (see Fig. 14). Typi-
cally, there is significant increase in size of this
cystic mass of CHMTF from second to third
trimester, in contrast to PMD, which most
commonly decreases in size as the pregnancy
evolves.47PEARLS, PITFALLS, VARIANTS
Imagers should be aware of common pitfalls that
can happen in imaging for PASD. Loss of retropla-
cental clear space from excess probe pressure is a
well-known scenario, which can lead to overcalling
accreta. Hence, when this finding is present in
isolation without other features of PASD, probe
pressure should be reduced and reimaging per-
formed. Myometrial contractions can mimic
masses (Fig. 15). In addition, the presence of con-
tractions can lead to obscuration of this clear
space (see Fig. 15).
MR imaging pitfalls include the presence of
bulging of the uterus in patients without PASD.
Similar to other scenarios, this should be inter-
preted in combination with other findings.5 A
relatively homogeneous placenta without T2-
dark bands or abnormal vascularity may be
placenta implanted in the region of scar that is
ballooning with the pressure of gestation,
without the presence of PASD. Occasionally,Fig. 14. Complete hyaditiform mole
with twin fetus. (A) Transabdominal
US at 24 weeks and (B) corresponding
sagittal T2W MR image demonstrates
a large cystic mass (asterisk), separate
from placenta and a normally devel-
oped cotwin (arrow).
Fig. 15. Myometrial contraction as a mimic of PASD and focal mass. (A) Longitudinal US sweep of the placenta
(PL) demonstrates retroplacental ill-defined focal masslike area (arrow), mimicking a retroplacental mass and
obscuring the retroplacental interface. (B) This finding resolved later in the study (arrowheads) compatible
with a contraction. (C, D) Transabdominal US grayscale image demonstrates focal retroplacental irregular mass-
like area (arrow), which demonstrated focal area of hypervascularity (short arrow) on color Doppler image. This
finding suggests focal contraction and can be misinterpreted as a mass. (E) Coronal T2W MR image demonstrates
a retroplacental low-signal irregular mass (arrow) in keeping with a typical MR imaging appearance of focal my-
ometrial contraction, which is a physiologic finding throughout the pregnancy.
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Cervical varices are another common pitfall that
can be misinterpreted as placental pathology.
These patients present with vaginal bleeding,
which can be profuse. Often the indication for
imaging is suspicion for vasa previa and placenta
previa. On US, varices are seen as tubular,
anechoic to hypoechoic structures, which should
connect to maternal vasculature (Fig. 16). Mostcommonly, these can be traced to connect to
maternal myometrial vessels. Given the physio-
logic venous engorgement during pregnancy,
some of these vessels become variceal and
can even prolapse into the cervix and upper va-
gina. Spectral interrogation demonstrates
venous waveforms. MR imaging features are
those of a vessel, seen as a flow void in the re-
gion of the cervix and connecting to myometrial
Fig. 16. Cervical varix. (A) Transabdominal color Doppler US of lower uterine segment and cervix in a pregnant
woman presenting with multiple episodes of vaginal bleeding demonstrates prolapsed vascular structure in the
cervical canal (arrow). (B) Spectral Doppler confirms venous flow that suggests a cervical varix. (C) On speculum
examination a “blue bag of worms” appearance of the cervix was noted. (D) Sagittal T2WMR image shows edem-
atous cervical stroma (arrow) with central flow voids (short arrow). (E) After transvaginal cerclage placement (ar-
row), color Doppler US shows no demonstrable color Doppler flow in the cervical canal. (F) Corresponding MR
images shows decreased stromal T2 signal and collapsed vascular structures, which supports a thrombosed varix
post cerclage placement.
Jha et al396vessels (see Fig. 15). Differential includes the
marginal vein of the placenta, which is located
at the edge of the placental disc and does not
connect to myometrial vasculature. Varices can
develop throughout the pelvis during pregnancy
and can develop in unusual locations such as
along the round ligaments, where they can pre-
sent as palpable abnormalities and mimic an
inguinal hernia (Fig. 17).
Thrombohematomas, also known as Breus
mole, can mimic a placental mass.47 Presence
of myometrial contractions can also lead to glob-
ular appearance of subjacent placenta, which
can mimic a placental mass; however, the
“masslike” area will be very similar to the
placenta in echogenicity.47 Doppler imaging
can be useful in this circumstance where the un-
derlying area has similar vascularity. This should
be addressed by the reimaging after the contrac-
tion has resolved.WHAT THE REFERRING PHYSICIAN NEEDS TO
KNOW
Imaging of PASD is focused on diagnosing the
presence and extent of involvement, depth of
placental invasion, if possible, extrauterine
extension, and presurgical planning. Once the
presence of PASD has been established, the
radiologist should focus on assessing the loca-
tion of the placenta and depth of invasion. Pres-
ence of placental bulge sign has been shown to
be a marker for at least myometrial invasive dis-
ease. When combined with serosal hypervascu-
larity, findings are highly suspicious for
placenta percreta with extrauterine extension.
Assessment of the extent of abnormal serosal
vascularity can help predict the needs for addi-
tional hemostatic measures such as interven-
tional radiology embolization. Proximity of the
placenta with the bladder, specially posteriorly,
Fig. 17. Round ligament varices in a
patient presenting with right groin
lump, which developed and pro-
gressed during pregnancy. Clinical
concern was for inguinal hernia. (A)
Transabdominal US showed tubular
structures (arrow), which demon-
strated flow on (B) color Doppler im-
ages (arrow). Findings in keeping
with pregnancy-related round liga-
ment varices.
Nonfetal Imaging During Pregnancy 397prompts cystoscopy at the time of delivery,
possible placement of ureteral stents, creation
of bladder patch at surgery, and urology involve-
ment with worse involvement.
MR imaging allows to distinguish hematomas
from other causes of antepartum bleeding and
pain, such as vasa previa, degenerated uterine
fibroid, cervical pathology, and placental tumors.
Moreover, MR imaging helps to determine the
age of the blood products based on MR signal
characteristics of hemoglobin. Consequently,
placental bleeding can be categorized into hyper-
acute, acute, early subacute, late subacute, and
chronic hematomas. Hyperacute and acute
placental hematomas are considered unstable he-
matomas with higher risk of rapid progression or
rebleeding, which may require change in
management.
In cases with placental masses, the goal of im-
aging is to characterize the mass and evaluate
fetal well-being. Chorioangiomas can cause fetal
anemia, polyhydramnios, chorioamniotic separa-
tion, and even hydrops. The larger the size of the
mass, the higher the risk of complications. If a
fetal intervention is anticipated, as in the setting
of fetal anemia, knowing the location of
the placenta and cord insertion is helpful to
assess the feasibility and access for in utero
transfusion.
SUMMARY
In summary, the placenta should be evaluated at
the time of fetal evaluation with US. Potential risk
factors for PASD should be elicited and if present,
features of PASD should be evaluated for their
presence. Prenatal diagnosis of PASD is essential
for appropriate management and activation of
multidisciplinary teams. Placental masses are un-
common and can be divided into trophoblastic
and nontrophoblastic masses. Molar pregnancies
and choriocarcinomas are trophoblastic masses.
Although most nontrophoblastic placental masses
are benign, the management focuses on the fetal
well-being.REFERENCES
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